Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Korro Bio, Inc.
IPO Date: October 4, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $129.59M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.92 | 4.37%
Avg Daily Range (30 D): $1.03 | 6.44%
Avg Daily Range (90 D): $1.12 | 5.36%
Institutional Daily Volume
Avg Daily Volume: .3M
Avg Daily Volume (30 D): .08M
Avg Daily Volume (90 D): .07M
Trade Size
Avg Trade Size (Sh.): 136
Avg Trade Size (Sh.) (30 D): 52
Avg Trade Size (Sh.) (90 D): 50
Institutional Trades
Total Inst.Trades: 265
Avg Inst. Trade: $1.93M
Avg Inst. Trade (30 D): $.61M
Avg Inst. Trade (90 D): $.94M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.78M
Avg Closing Trade (30 D): $1.69M
Avg Closing Trade (90 D): $1.69M
Avg Closing Volume: 143.32K
       
News
Mar 14, 2025 @ 12:00 PM
KRRO-110 Receives Orphan Drug Designation from U.S...
Source: N/A
Nov 8, 2024 @ 7:34 AM
4 Biotech Stocks With AI, Machine Learning Prowess...
Source: Professor Ari Zoldan
Sep 19, 2024 @ 10:50 AM
Novo Nordisk Just Took a $530 Million Step Onto Mo...
Source: The Motley Fool
May 20, 2024 @ 6:30 PM
Korro Presents Additional Preclinical Data for KRR...
Source: Korro Bio, Inc.
May 14, 2024 @ 8:01 PM
Korro Reports First Quarter 2024 Financial Results...
Source: Korro Bio, Inc.
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-2.49 $-2.26 $-9.37
Diluted EPS $-2.49 $-2.26 $-9.37
Revenue $ 2.55M $ 2.27M $ 2.27M
Gross Profit $ $ $
Net Income / Loss $ -23.39M $ -21.2M $ -83.58M
Operating Income / Loss $ -25.02M $ -23.04M $ -91.91M
Cost of Revenue $ $ $
Net Cash Flow $ 8.5M $ -9.33M $ -114.07M
PE Ratio